Analyst Targets Suggest Potential Growth for iShares Russell 1000 Growth ETF
At ETF Channel, we analyzed the underlying holdings of various ETFs. Our focus turned to the iShares Russell 1000 Growth ETF (Symbol: IWF), which shows a promising outlook. Based on the weighted average implied analyst target price, IWF is projected to reach $467.59 per share.
Current Valuation and Potential Upside
Presently, IWF trades around $416.37 per share. This indicates that analysts foresee a 12.30% increase in value over the next year, based on their target prices for the ETF’s holdings. Notably, three stocks within IWF have significant upside potential: Apellis Pharmaceuticals Inc (Symbol: APLS), e.l.f. Beauty Inc (Symbol: ELF), and Repligen Corp. (Symbol: RGEN). APLS, currently at $27.40 per share, has an average analyst target price of $46.10, reflecting a possible 68.25% upside. Additionally, shares of ELF, priced at $73.00, may rise 33.82% to a target of $97.69. RGEN also shows a robust outlook, with a target of $188.21, a 28.11% increase from its recent price of $146.92. Below is a chart illustrating the twelve-month stock performance of APLS, ELF, and RGEN:
Summary of Analyst Target Prices
The following table summarizes the current analyst target prices for the mentioned stocks:
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| iShares Russell 1000 Growth ETF | IWF | $416.37 | $467.59 | 12.30% |
| Apellis Pharmaceuticals Inc | APLS | $27.40 | $46.10 | 68.25% |
| e.l.f. Beauty Inc | ELF | $73.00 | $97.69 | 33.82% |
| Repligen Corp. | RGEN | $146.92 | $188.21 | 28.11% |
Analyzing Patterns in Analyst Predictions
Investors might wonder if these targets are realistic or perhaps too optimistic regarding the future performance of these stocks. It is essential to consider whether analysts have valid reasoning behind their target prices or if they may be lagging behind recent developments in the companies and their respective industries. A high target often suggests confidence in future growth but could lead to potential downgrades if those projections do not align with market realities.
10 ETFs With Most Upside To Analyst Targets »
Explore More:
• Manufacturing Dividend Stock List
• PDCO YTD Return
• YOSH Shares Outstanding History
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
